Clinical trial Recruiting at 1 site Interventional Ages 4 to 70

Non-invasive spinal stimulation to improve walking in neurological patients

Official title: Transcutaneous Spinal Stimulation With Intensive Gait Training for Individuals With Neurologic Conditions

Run by University of Washington · NCT04467437 · Data updated 2026-11-12

This study is testing if non-invasive spinal stimulation can help people with neurological disorders improve their walking ability when combined with gait training.

Quick facts

Study typeInterventional
Ages4 Years to 70 Years
SexAll
Enrollment20 (estimated)
SponsorUniversity of Washington
Academic / other
Locations1 site (Seattle, Washington)
StatusRecruiting
StartedJanuary 1, 2021
Main results expectedAugust 2026
Study endsDecember 2027
Registry record updatedSeptember 19, 2024
Trial IDNCT04467437 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with neurological conditions who can walk 20 yards and are capable of participating in physical therapy sessions.

Probably not a fit

Patients with significant medical diseases or conditions that prevent full participation in physical therapy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effects of non-invasive spinal cord stimulation on walking function in individuals with neurological disorders, such as cerebral palsy and stroke. Participants will undergo a cross-over design where they will receive intensive gait training either alone or combined with spinal stimulation. The study aims to assess the impact of this stimulation on spasticity and locomotor function, as well as gather participant feedback on their experiences. The intervention will last up to 11 months, with participants attending up to five sessions per week.

Why it matters

Potential benefit: If successful, this approach could significantly enhance walking abilities and overall mobility for patients with neurological conditions.

How similar studies have gone: Previous studies have shown positive outcomes with spinal stimulation in spinal cord injury patients, suggesting potential for success in similar neurological conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* have a neurologic condition
* can walk 20 yards, with or without an assistive device
* have stable medical condition
* are capable of performing simple cued motor tasks and who can follow 2-3 step commands
* have ability to attend up to 5 sessions per week physical therapy sessions and testing activities
* have adequate social support to be able to participate in training and assessment sessions, up to 5 sessions per week, for the duration of up to 11 months within the study period.
* who are volunteering to be involved in this study
* can read and speak English

Exclusion Criteria:

* have significant medical disease; including uncontrolled systemic hypertension with values above 170/100 mmHg; cardiac or pulmonary disease; uncorrected coagulation abnormalities or need for therapeutic anticoagulation.
* have cardiovascular or musculoskeletal disease or injury that would prevent full participation in physical therapy intervention
* have a history of uncontrolled seizures
* have unhealed fracture or other musculoskeletal impairment that might interfere with lower extremity rehabilitation or testing activities
* are dependent on ventilation support
* have implanted stimulator (e.g. epidural stimulator, vagus nerve stimulator, pacemaker, cochlear implant, etc) or drug delivery device (e.g. baclofen pump)
* have history of orthopedic surgery in lower extremities or neurosurgery that may be a confounding factor for interpretation of the results (such as tendon transfer, tendon or muscle lengthening for spasticity management, injection therapies to lower extremity muscles, etc.) in last 12 months
* have established osteoporosis and taking medication for osteoporosis treatment.
* have rheumatic diseases (rheumatoid arthritis, systemic lupus erythematosus, etc.)
* have active cancer

Where it's running

  • University of Washington
    Seattle, Washington, United States
    Recruiting

Study contacts

  • Principal investigator: Katherine M Steele, PhD — University of Washington
  • Study coordinator: Siddhi R Shrivastav, BPTh, MS
  • Email: siddhis@uw.edu
  • Phone: 973-444-1940

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.